1.
Cristiano A, Palmieri R, Fabiani E, Ottone T, Divona M, Savi A, et al. The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID : VEN/AZA effectively targets AML clones. Mediterr J Hematol Infect Dis [Internet]. 2022 Apr. 28 [cited 2024 Mar. 2];14(1):e2022041. Available from: https://mjhid.org/mjhid/article/view/4965